Molplex Pharmaceuticals
AI, automated decision-making drive drug discovery
This article was originally published in Start Up
Executive Summary
Molplex Pharmaceuticals’ drug discovery platform, Optiplex, uses a combination of artificial intelligence and highly automated decision-making systems in drug optimization, selecting compounds with maximum potential for efficacy combined with minimum side effects. The Optiplex database contains almost a trillion chemical structures, as well as predicted biological activities for more than a thousand human protein targets and ADME-tox properties.